You are here: Industry Insights > Roche

News List

Roche scrambles to boost Herceptin supply in China after insurance OK triggers shortage fiercepharma
June 06, 2018
When Roche got Herceptin onto China’s national insurance program, it didn’t expect demand to surge so quickly, overwhelming its production capacity there.
Roche says first-line Tecentriq combination meets main goals in Phase III non-squamous NSCLC study firstwordpharma
May 30, 2018
Roche announced Phase III results Tuesday showing that patients with advanced non-squamous non-small-cell lung cancer (NSCLC) who took the company's PD-L1 inhibitor Tecentriq (atezolizumab) plus chemotherapy as a first-line treatment achieved significantl
Roche Announces HAVEN 3 & HAVEN 4 Study Results contractpharma
May 22, 2018
Roche announced full results from the phase III HAVEN 3 study evaluating Hemlibra® (emicizumab) prophylaxis administered every week
Lodo and Roche go digging for drug candidates, after $1bn deal pharmafile
May 15, 2018
Discovering potential therapeutics from natural sources has been a constant throughout the evolution of medicine, Lodo Therapeutics, however, has taken it one step further via its soil-sequencing approach.
What biosimilar threat? Roche wins another reprieve as FDA stiff-arms Novartis Rituxan copy fiercepharma
May 04, 2018
Roche's Rituxan just got another biosim break. Rival drugmaker Novartis said late Wednesday its knockoff version didn't pass muster at the FDA.
Roche reports a strong start in 2018 worldpharmanews
May 02, 2018
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced that in the first three months of 2018, Group sales rose 6% to CHF 13.6 billion.
FM, Roche, DIAN collaborate for Personalized Cancer Care in China biospectrumasia
April 28, 2018
DIAN is one of the leading independent medical laboratories in China and is dedicated to innovation in diagnostic testing platforms.
Mixed results from Roche’s key new drugs in Q1 pharmaphorum
April 27, 2018
Roche is relying on new drugs such as Ocrevus for multiple sclerosis and cancer drug Tecentriq to recoup sales as its big three blockbuster drugs are facing generic competition.
Roche and Subsidiaries Ramp Up Treatment Options for Multiple Sclerosis biospace
April 24, 2018
Roche and its subsidiaries are ramping up treatment options for multiple sclerosis.
Final NHS nod for Roche’s RoActemra pharmatimes
April 20, 2018
Roche/Chugai’s RoActemra should be routinely offered throughout the NHS to adults with giant cell arteritis (GCA) within the next three months, following a final green light from cost regulators.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page